Triton Wealth Management’s Bionano Genomics BNGO Stock Holding History
Bought
Maintained
Sold
Other funds holding BNGO
PVI
Triton Wealth Management's BNGO Position: Q1 2021 in Review
Triton Wealth Management sold out of Bionano Genomics (BNGO) in Q1 2021, closing a stake of 31 shares — an estimated $93K sold.
Triton Wealth Management first reported a position in BNGO in Q2 2020 and held it in 3 quarters. The position peaked at $93K in Q4 2020. 109 funds tracked by Wall St. Rank hold BNGO as of Q1 2021.
- Triton Wealth Management reported no remaining Bionano Genomics position as of Q1 2021 after selling out during the quarter.
- Triton Wealth Management sold 31 Bionano Genomics shares in Q1 2021, an estimated $93K.
- Triton Wealth Management first reported a position in Bionano Genomics in Q2 2020 and held it in 3 quarters.
- Triton Wealth Management's Bionano Genomics position peaked at $93K in Q4 2020.
- 109 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2021.
Based on Triton Wealth Management's 13F filing for Q1 2021, filed 19 Apr 2021.